Market Newsdesk

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca’s pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving ERAS-0015.

The lawsuit seeks to represent investors who purchased or otherwise acquired Erasca common stock between January 14, 2025 and April 26, 2026.

National shareholder rights law firm Hagens Berman is continuing its investigation into legal claims that Erasca violated the federal securities laws and urges Erasca investors who suffered significant losses to contact the firm now to discuss their rights.

Class Period: Jan. 14, 2025 – Apr. 26, 2026
Lead Plaintiff Deadline: Aug. 10, 2026
Visit:www.hbsslaw.com/investor-fraud/eras
Contact the Firm Now:[email protected]
                                        844-916-0895

Erasca, Inc. (ERAS) Securities Class Action:

Precision oncology company Erasca’s ERAS-0015 is the company’s investigational, oral, potentially “best-in-class” pan-RAS molecular glue under development to treat RAS-mutant solid tumors, including pancreatic ductal adenocarcinoma.

The complaint alleges that Erasca favorably compared the equivalence of its ERAS-0015 40 milligram dose cohort to RevMed’s RMC-6236 400 milligram dose cohort. In addition, as recently as March 12, 2026, Erasca allegedly assured investors of its ERAS-0015 intellectual property protection, and touted that its ERAS-0015 has “in-licensed one patent family from Joyo” that “includes one issued US patent, one pending US non-provisional patent application, one issued foreign patent, and thirteen pending foreign patent applications.”

The complaint alleges that Erasca misled the market because, unknown to investors, comparisons of ERAS-0015 to RMC-6236 were improper, exposed the company to intellectual property disputes, and as a result the company’s proffers about ERAS-0015 lacked a reasonable basis.

The truth allegedly emerged on April 27, 2026. That day, Erasca disclosed two important matters concerning the ERAS-0015 “best-in-class” narrative.

First, before the market opened, Erasca disclosed that it received a letter from RevMed’s legal counsel challenging the validity of Erasca’s intellectual property claims. RevMed contends Erasca obtained RevMed’s trade secrets through third-party misappropriation and deceptively compared the competing therapies.

Second, after the market closed, the company revealed that a patient being treated with ERAS-0015 suffered an adverse event, presented to the ER a month after receiving the treatment, and then died.

The market swiftly reacted to these disclosures, sending the price of Erasca shares down $9.25 (-48%) the next day and wiping out over $2.8 billion of Erasca’s market capitalization.

“We’re investigating whether Erasca may have intentionally misled investors about ERAS-0015’s safety profile and about a potential moat in its particular, highly competitive cancer treatment space,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Erasca and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to other frequently asked questions about the Erasca case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Erasca should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — National shareholder rights firm Hagens Berman is investigating claims alleged in a pending securities class action suit against Roblox Corporation (NYSE: RBLX) and its management following disclosures that the company’s age verification rollout caused significant, undisclosed friction to its user growth and platform engagement.

SUBMIT YOUR RBLX LOSSES TO HBSS NOW

The firm’s investigation focuses on the suit’s claims that Defendants misled investors regarding the operational consequences of the safety-focused initiatives the company had purportedly implemented.
Allegations Concerning Age Verification and Growth:

The suit follows a sharp decline in Roblox’s share price on May 1, 2026, after the company reported its Q1 2026 financial results. The core allegations, which have emerged in recently filed complaint against the company, contend that Roblox failed to disclose that its age-check rollout:

• Reduced Platform Engagement: The age verification features hindered on-platform communication, leading to a decline in user interaction.
• Negatively Impacted Organic Growth: The friction caused by these features resulted in lower app store ratings and a corresponding reduction in organic user sign-ups.
• Misrepresented Growth Potential: Throughout the class period (October 30, 2025 – April 30, 2026), Roblox characterized the rollout as a “gold standard” implementation while allegedly knowing it would lead to a significant slowdown in user growth.

Key Disclosures and Market Impact

• April 30, 2026: Roblox revealed a steep deceleration in year-over-year and sequential DAU growth, slashed its 2026 revenue guidance and severely cut its 2026 bookings growth. The company blamed its dismal results on just 51% of Roblox global DAUs having age checked. The company further revealed that “as a result of age check […] we have seen a reduction in app store ratings, and we believe this may be contributing to a reduction in organic sign-ups that typically flow from app stores.” Roblox also said its lowered prospects are the result of “continued friction” resulting from the age-check rollout.
• Market Correction: The news caused Roblox shares to fall $10.13, or approximately 18.33%, on May 1, 2026, erasing over $6.7 billion in market capitalization.

Hagens Berman’s Investigation

“We’re focused on when Roblox and its management knew of the adverse consequences of the age-check rollout and whether they intentionally misled investors about it,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.
Investor Rights and Lead Plaintiff Deadline

Hagens Berman is currently evaluating the claims alleged in the suit brought on behalf of a putative class of investors who purchased Roblox securities between October 30, 2025, and April 30, 2026. If you suffered financial losses on RBLX during the class period, you are encouraged to contact our office to learn more about your legal rights and the ongoing class action litigation. The court-imposed deadline to move for appointment as lead plaintiff is August 7, 2026.

• 
  Report your losses now
  
• Contact Our Attorneys:
  
  [email protected]
  
• Investor Hotline: 844-916-0895
• Hagens Berman’s Roblox Page:
  
  www.hbsslaw.com/cases/roblox
  

If you’d like more information and answers to other frequently asked questions about the Roblox case and the firm’s investigation, read more.

Whistleblowers: Persons with non-public information regarding Roblox should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company’s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts’ questions.

These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws.

The firm encourages Embecta investors who suffered substantial losses to submit your losses now.

Class Period: Nov. 25, 2025 – May 4, 2026
Lead Plaintiff Deadline: Aug. 17, 2026
Visit:www.hbsslaw.com/investor-fraud/embc
Contact the Firm Now: [email protected]
                                          844-916-0895

Embecta Corp. (EMBC) Securities Class Action:

Embecta is a global medical device company whose core business product is pen needles – sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. In the past, pen needle revenues have comprised over 70% of the company’s total revenues.

The litigation’s primary focus is on the propriety of Embecta’s Class Period repeated assurances that “insulin pens have been stable […] showing the underlying resilience and the durability of that portfolio[]” and “our pen needle business is incredibly resolute.” This narrative formed the basis for the company’s February 5, 2026 guidance reiterating 2026 adjusted EPS of $2.80 – $3.00. The company also touted maintenance of its dividend within its capital allocation plans as a return of capital to shareholders.

The complaint alleges the company’s assurances and guidance were misleading when given because Embecta knew or recklessly disregarded that weaknesses in the pen needle market was likely to significantly disrupt the company’s annual guidance and Q2 results.

On May 5, 2026, investors’ expectations vanished. That day, Embecta reported Q2 2026 adjusted EPS of $0.27, a staggering sequential and year-over-year decline of about 61%. In contrast to the company’s assurances of stability, resilience, and durability, Embecta’s pen needles revenues also suffered massive sequential and year-over-year declines. Of additional concern, Embecta slashed its 2026 adjusted EPS guidance to $1.55 – $1.75, or down roughly 43% at the mid-point, and reduced its dividend by 93% to just $0.01.

In response, the market sent the price of Embecta shares tumbling, with one prominent analyst who downgraded the company highlighting Embecta management’s “need to rebuild investor credibility on commercial execution and the profitability outlook.”

“Our investigation is focused the extent to which and when Embecta and its management knew about pen needle and U.S. business revenue headwinds, and whether they were sufficiently transparent about those risks,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Embecta and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to other frequently asked questions about the Embecta case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Embecta should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895

ATLANTA, July 08, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended June 30, 2026, on Friday, August 7, 2026.

Earnings Conference Call Information

Gray Media, Inc. will host a conference call to discuss its operating results for the quarter ended June 30, 2026, on Friday, August 7, 2026. The call will begin at 11:00 a.m. Eastern Time. The live dial-in number is 1-800-715-9871 (or 1-646-307-1963.) All participants who dial in will be asked for their name and conference ID (3663076) or the name of the call (Gray Media Q2 Call) and will be placed on music hold prior to the start of the conference. Participants should dial in 10-15 minutes before the conference is scheduled to begin. The call will be webcast live and available for replay at www.graymedia.com. The taped replay of the conference call will be available at 1-800-770-2030 using conference ID 3663076# until September 4, 2026.

About Gray Media:


        
Gray Media, Inc. (NYSE: GTN) is a multimedia company headquartered in Atlanta, Georgia. We are the nation’s largest owner of top-rated local television stations and digital assets. As of May 15, 2026, we serve 117 full-power television markets that collectively reach approximately 37% of US television households. The portfolio includes 78 markets with the top-rated television station and 101 markets with the first and/or second highest-rated television station in average all-day ratings across the 116 of such markets that were measured by Nielsen in 2025. We also own the largest Telemundo Affiliate group with 46 markets and Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with the most advanced digital products and services. Our additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. For more information, please visit www.graymedia.com.

Gray Contact:

Jeff Gignac, Executive Vice President, Chief Financial Officer, 404-504-9828
Alan Gould, Vice President, Investor Relations, 404-266-8333

# # #

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) faces a securities class action lawsuit related to disclosures the company made to investors within its initial public offering documents whereby it issued about 16.9 million shares to investors at $20 per share. The lawsuit seeks to represent investors who purchased or otherwise acquired Black Rock common stock in and/or traceable to the company’s September 2025 IPO.

By the time the lawsuit was filed on June 18, 2026, Black Rock Coffee shares had steadily declined to $7.72, or over 61% below the IPO price.

The recent revelations about Black Rock Coffee’s slowing growth metrics and severe share price decline support national shareholder rights firm Hagens Berman’s investigation into legal claims that Black Rock and its co-defendants violated the federal securities laws.

The firm encourages Black Rock investors who suffered substantial losses to submit your losses now.

Lead Plaintiff Deadline: Aug. 17, 2026
Visit: www.hbsslaw.com/investor-fraud/brcb
Contact the Firm Now:	[email protected]
	844-916-0895

Black Rock Coffee Bar, Inc. (BRCB) Securities Class Action:

Black Rock characterizes itself as a “high-growth operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by our engaging baristas.”

Within the company’s offering documents, it touted an aggressive growth story, stating that it has opened and plans to open additional stores in markets where it has little or no operating experience. To support its business plan, Black Rock cited metrics such as increasing store count, increasing store revenue, increasing same store sales (“SSS”) growth, increasing income from operations, and others.

The complaint alleges that Black Rock’s IPO documents misled investors because they did not disclose critical information to investors, such as new store openings were leading to a cannibalization of its existing services and revenue. In addition, the complaint alleges that Black Rock overstated the manner in which its expansion strategy was tailored to avoid situations where a portion of volume from existing stores shifts to newer stores in closer proximity to customers (“sales transfer”) that negatively affected revenue growth.

On May 12, 2026, Black Rock reported its Q1 2026 financial results. The company reported a large sequential decrease (-44%) in SSS growth – down from 9.3% to 5.2%. Of critical importance, during the earnings call that day, management revealed that the sales transfer phenomenon (i.e. cannibalization) created a 160-basis point headwind to SSS growth, raising doubts about the efficacy of Black Rock’s expansion strategy.

The company also reported opening nine new stores during the quarter, yet sequentially added just $1.9 million of revenues representing a slowing sequential growth rate to about 3.5%.

In response, the market drove the price of Black Rock shares down $3.32 (-30%) on May 13, 2026.

“We’re focused on whether Black Rock Coffee’s IPO documents were negligently prepared for failing to disclose adverse facts about the sales transfer phenomenon embedded in the company’s growth strategy,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Black Rock Coffee and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to other frequently asked questions about the Black Rock Coffee case and the firm’s investigation, read more.

Whistleblowers: Persons with non-public information regarding Black Rock Coffee should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case. 

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — Hub Group, Inc. (NASDAQ: HUBG) and certain of its current and former executives (together, “co-defendants”) face a securities class action lawsuit, which seeks to represent investors who purchased or acquired Hub Group securities between April 28, 2023 and May 11, 2026.

The development follows the company’s surprise revelations that its financial reports going back to 2023 were “materially misstated and should no longer be relied upon” and corrective actions taken against two senior executives.

National shareholder rights firm Hagens Berman continues to investigate legal claims that Hub Group and its co-defendants violated the federal securities laws and urges investors who suffered significant losses to submit your losses now.

Class Period: Apr. 28, 2023 – May 11, 2026
Lead Plaintiff Deadline: Aug. 28, 2026
Visit:www.hbsslaw.com/investor-fraud/hubg
Contact the Firm Now:[email protected]
                                                    844-916-0895

Hub Group, Inc. (HUBG) Securities Class Action:

The lawsuit focuses on the propriety of Hub Group’s repeated assurances that its financial statements were prepared in conformity with applicable accounting rules.

Contrary to these assurances, the complaint alleges that throughout the Class Period the co-defendants made false and misleading statements concerning Hub Group’s premature and incorrect revenue recognition and understatement of purchased transportation costs and accounts payable.

Investors learned the truth through a series of Hub Group’s partial disclosures about its accounting and ramifications for certain of its executives.

First, on February 6, 2026, investors saw the price of their Hub Group shares crater $9.37 (-18%) after the company (while touting that “[a]ccuracy and transparency in reporting on our performance is of utmost importance[]”) revealed that during the first nine months of 2025 it had understated purchased transportation costs and accounts receivable by $77 million. Accordingly, the company said investors should not rely on its Q1 – Q3 2025 financial statements and it plans to restate them.

Second, on May 12, Hub Group shares tumbled again – this time, shares fell $5.24 (-12.5%) – on new disclosures much worse than on February 6. The company said its financial statements for the years ended December 31, 2023 and 2024 were materially misstated and that investors should no longer rely on those either. Hub Group explained only that it “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported[]” and cautioned it was continuing to review “additional accounting issues that may potentially further impact” the 2023 and 2024 financial statements.

Between February 5, 2026 (the day before Hub Group’s first partial corrective disclosure) and May 12, 2026, shareholders have seen over $890 million of Hub Group’s market capitalization wiped out.

After the Class Period, on June 2, 2026, Hub Group announced that Chief Financial Officer Kevin Beth and Chief Operating Officer Brian Meents both left the company on May 27. The company said the executive departures were part of its corrective actions related to its financial statement review.

“Now that Hub Group has almost cleaned out its C-suite following accounting improprieties reaching all the way back to 2023, the core focus of our investigation is whether they were intentional or reckless with the goal of making financial metrics appear better than they actually were. We’re also looking to see whether additional problems will surface when the company’s review is completed,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Hub Group and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to other frequently asked questions about the Hub Group case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Hub Group should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) — Peabody Energy Corporation (NYSE: BTU) faces a securities class action lawsuit related to surprise disclosures the company made to investors on March 30 and May 5, 2026 about problems with its flagship metallurgical coal asset (“Centurion”).

The lawsuit seeks to represent investors who purchased or otherwise acquired shares of Peabody common stock between October 14, 2024 and May 4, 2026.

Between March 27 (the trading day before the first cryptic disclosure) and the May 5, 2026 fuller disclosure, investors saw the price of Peabody shares crumble $14.50 (-36%). Accordingly, the severe market reactions upon the company’s revelations support national shareholder rights firm Hagens Berman’s investigation into legal claims that Peabody and its co-defendants violated the federal securities laws.

The firm encourages Peabody investors who suffered substantial losses to submit your losses now.

Class Period: Oct. 14, 2024 – May 4, 2026
Lead Plaintiff Deadline: Aug. 24, 2026
Visit: www.hbsslaw.com/investor-fraud/btu
Contact the Firm Now:	[email protected]
	844-916-0895

Peabody Energy Corporation (BTU) Securities Class Action:

Peabody characterizes itself as a leading producer of metallurgical and thermal coal and has promoted Centurion, its underground longwall metallurgical coal mine in Queensland, Australia. According to the company, the mine commenced full-scale production in February 2026.

The litigation is focused on the propriety of Peabody’s statements about Centurion’s operational status and production capabilities.

For example, Peabody’s management informed investors on February 5, 2026 that “the team was installing the very last shield and putting the finishing touches on the Centurion Mine[,]” and “our team is charged up and has started mining some of the best metallurgical coal in the world.” The company and its management also assured investors that Centurion is “going to ramp up probably about 700,000 tons in Q1, about 1 million to 1.1 million tons in Q2 and Q3, and then it’ll fall back down in Q4 as we have a longwall move.” In response, the market rewarded these statements by sending the price of Peabody shares up about 7.8% the next day.

Just a few weeks later, on March 30, 2026, Peabody filed a current report with the SEC and abruptly disclosed that Centurion “is expected deliver approximately 250,000 tons in the first quarter[.]” In other words, the company slashed Centurion production by about 64%. The news sent the price of Peabody shares down almost 10%.

Then, on May 5, 2026, Peabody reported its Q1 2026 financial results. Of particular concern pertaining to Centurion, management revealed the truth about why it slashed the mine’s Q1 production assurance.

Despite telling investors in February that it was mining Centurion and would produce 700,000 tons in Q1, a new narrative emerged – “as part of our commissioning in February, we encountered temporary mechanical and electrical issues” – and “[a]s a result, our full year sales outlook for Centurion is now 2.5 million tons compared to our original expectation of 3.5 million tons.” This full year 28% reduction helped send the price of Peabody shares down nearly 6%.

“We’re focused on whether Peabody and its management were sufficiently transparent about Centurion’s operational capabilities during the Class Period and, if not, whether they violated federal securities laws,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Peabody Energy and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to other frequently asked questions about the Peabody case and the firm’s investigation, read more.

Whistleblowers: Persons with non-public information regarding Peabody Energy should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895